A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus

被引:14
作者
Kawamura, Kazunori [1 ]
Shimoda, Yoko [1 ]
Yui, Joji [1 ]
Zhang, Yiding [1 ]
Yamasaki, Tomoteru [1 ]
Wakizaka, Hidekatsu [2 ]
Hatori, Akiko [1 ]
Xie, Lin [1 ]
Kumata, Katsushi [1 ]
Fujinaga, Masayuki [1 ]
Ogawa, Masanao [1 ,3 ]
Kurihara, Yusuke [1 ,3 ]
Nengaki, Nobuki [1 ,3 ]
Zhang, Ming-Rong [1 ]
机构
[1] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiopharmaceut Dev, Chiba 2638555, Japan
[2] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Med Phys, Chiba 2638555, Japan
[3] SHI Accelerator Serv Ltd, Tokyo 1410032, Japan
关键词
Ultra-high specific radioactivity; C-11; Imidazoline receptors; I-2; BU99008; PET; POSITRON-EMISSION-TOMOGRAPHY; I-2 IMIDAZOLINE RECEPTORS; IN-VIVO EVALUATION; PROTEIN; 18; KDA; BINDING-SITES; RAT-BRAIN; PARKINSONS-DISEASE; MAJOR DEPRESSION; SUICIDE VICTIMS; LIGAND;
D O I
10.1016/j.nucmedbio.2016.10.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: A positron emission tomography (PET) probe with ultra-high specific radioactivity (SA) enables measuring high receptor specific binding in brain regions by avoiding mass effect of the PET probe itself. It has been reported that PET probe with ultra-high SA can detect small change caused by endogenous or exogenous ligand. Recently, Kealey et al. developed [C-11]BU99008, a more potent PET probe for I-2-imidazoline receptors (I(2)Rs) imaging, with a conventional SA (mean 76 GBq/mu mol) showed higher specific binding in the brain. Here, to detect small change of specific binding for I(2)Rs caused by endogenous or exogenous ligand in an extremely small region, such as hypothalamus in the brain, we synthesized and evaluated [C-11]BU99008 with ultra-high SA as a useful PET probe for small-animal PET imaging of I(2)Rs. Methods: [C-11]BU99008 was prepared by [C-11]methylation of N-desmethyl precursor with [C-11]methyl iodide. Biodistribution, metabolite analysis, and brain PET studies were conducted in rats. Results: [C-11]BU99008 with ultra-high SA in the range of 5400-16,600 GBq/mu mol were successfully synthesized (n = 7), and had appropriate radioactivity for in vivo study. In the biodistribution study, the mean radioactivity levels in all investigated tissues except for the kidney did not show significant difference between [C-11]BU99008 with ultra-high SA and that with conventional SA. In the metabolite analysis, the percentage of unchanged [C-11] BU99008 at 30 min after the injection of probes with ultra-high and conventional SA was similar in rat brain and plasma. In the PET study of rats' brain, radioactivity level (AUC(30-60) min) in the hypothalamus of rats injected with [C-11]BU99008 with ultra-high SA (64 [SUV center dot min]) was significantly higher than that observed for that with conventional SA (50 [SUV center dot min]). The specific binding of [C-11]BU99008 with ultra-high SA (86% of total binding) for I2R was higher than that of conventional SA (76% of total binding). Conclusion: A PET study using [C-11]BU99008 with ultra-high SA would thus contribute to the detection of small changes in or small regions with I2R expression and hence may be useful in elucidating new functions of I2R. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 42 条
  • [1] ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766
  • [2] In-target produced [11C]methane: Increased specific radioactivity
    Andersson, Jan
    Truong, Phong
    Halldin, Christer
    [J]. APPLIED RADIATION AND ISOTOPES, 2009, 67 (01) : 106 - 110
  • [3] BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
  • [4] Identification and characterization of I1 imidazoline receptors:: Their role in blood pressure regulation
    Bousquet, P
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (06) : 84S - 88S
  • [5] RS-45041-190 - A SELECTIVE, HIGH-AFFINITY LIGAND FOR I-2 IMIDAZOLINE RECEPTORS
    BROWN, CM
    MACKINNON, AC
    REDFERN, WS
    WILLIAMS, A
    LINTON, C
    STEWART, M
    CLAGUE, RU
    CLARK, R
    SPEDDING, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) : 1737 - 1744
  • [6] Imidazoline I2 receptor density increases with the malignancy of human gliomas
    Callado, LF
    Martín-Gómez, JI
    Ruiz, J
    Garibi, JM
    Meana, JJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (05) : 785 - 787
  • [7] THE IMIDAZOLINE SITE INVOLVED IN CONTROL OF INSULIN-SECRETION - CHARACTERISTICS THAT DISTINGUISH IT FROM I-1-SITE AND I-2-SITE
    CHAN, SLF
    BROWN, CA
    SCARPELLO, KE
    MORGAN, NG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) : 1065 - 1070
  • [8] Absolute quantification by positron emission tomography of the endogenous ligand
    Delforge, J
    Bottlaender, M
    Pappata, S
    Loc'h, C
    Syrota, A
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (05) : 613 - 630
  • [9] alpha(2)-adrenoceptors and I-2 sites in the mammalian central nervous system
    French, N
    [J]. PHARMACOLOGY & THERAPEUTICS, 1995, 68 (02) : 175 - 208
  • [10] Fukumura T, 2007, J LABELLED COMPD RAD, V50, pS202